Patrick Philibert
Overview
Explore the profile of Patrick Philibert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halfon P, Jordana S, Blachier S, Cartlamy P, Kbaier L, Psomas C, et al.
PLoS One
. 2023 Apr;
18(4):e0281257.
PMID: 37115758
Background: Identifying a specific threshold level of SARS-CoV-2 antibodies that confers protection in immunocompromised patients has been very challenging. The aim was to assess the threshold of 264 binding antibody...
2.
Psomas C, Penaranda G, Retornaz F, Khiri H, Delord M, Halfon P, et al.
J Virus Erad
. 2022 Mar;
8(1):100065.
PMID: 35251684
Background: MSM are at particular risk of STIs due to sexual behavior and substance use. HIV PrEP use may increase this risk. Design: Our aim was to comparatively assess incident...
3.
Spinner C, Felizarta F, Rizzardini G, Philibert P, Mitha E, Domingo P, et al.
Clin Infect Dis
. 2022 Jan;
75(5):786-794.
PMID: 34996113
Background: GSK3640254 (GSK'254) is a next-generation human immunodeficiency virus type 1 (HIV-1) maturation inhibitor with pharmacokinetics (PK) supporting once-daily therapy. Methods: This phase IIa double-blind (sponsor-unblinded), randomized, placebo-controlled, adaptive study...
4.
Halfon P, Penaranda G, Khiri H, Garcia V, Drouet H, Philibert P, et al.
PLoS One
. 2021 Sep;
16(9):e0257817.
PMID: 34555117
Background & Aim: We investigated the combination of rapid antigen detection (RAD) and RT-qPCR assays in a stepwise procedure to optimize the detection of COVID-19. Methods: From August 2020 to...
5.
Orkin C, Oka S, Philibert P, Brinson C, Bassa A, Gusev D, et al.
Lancet HIV
. 2021 Apr;
8(4):e185-e196.
PMID: 33794181
Background: There is a need for more convenient, less frequent treatment to help address challenges associated with daily oral HIV treatment in people living with HIV, including stigma, pill burden,...
6.
Orkin C, Arasteh K, Gorgolas Hernandez-Mora M, Pokrovsky V, Overton E, Girard P, et al.
N Engl J Med
. 2020 Mar;
382(12):1124-1135.
PMID: 32130806
Background: Long-acting injectable regimens may simplify therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection. Methods: We conducted a phase 3, randomized, open-label trial in which adults with...
7.
Psomas C, Philibert P, Kinloch S
J Virus Erad
. 2019 Feb;
5(1):67-72.
PMID: 30800430
No abstract available.
8.
Enel P, Retornaz F, Ravaux I, de Jaureguiberry J, Philibert P, Allegre T, et al.
AIDS Care
. 2018 Nov;
31(7):809-815.
PMID: 30466319
Aging persons living with HIV may develop multiple health problems, including comorbidities, and altered physical and mental health, earlier than non-infected people. They may also experience social deprivation. We assessed...
9.
Psomas C, Kinloch S, Sabin C, Soriano V, Solas C, Orkin C, et al.
J Virus Erad
. 2018 Jul;
4(3):196-207.
PMID: 30050686
The 20th International Symposium on HIV and Emerging Infectious Diseases took place in Marseille, France. It had a refreshing European look with reinforced partnerships with the European AIDS Clinical Society...
10.
Philibert P, Chiche L, Cailleres S, Allemand J, Rebaudet S, Delord M, et al.
AIDS
. 2017 Jul;
31(15):2167-2169.
PMID: 28692546
: We describe the first case of a patient presenting Kaposi's sarcoma with human herpes virus 8 (HHV8) viremia after switching from a protease inhibitor to an integrase inhibitor-based combination...